O1-13-5 - Treatment with R-bendamustine followed by Y-90 ibritumomab tiuxetan for relapsed/refractory low-grade B-cell lymphoma
| Autor: | Nikkuni, Koji, Abe, Takashi, Takai, Kazue |
|---|---|
| Zdroj: | In Annals of Oncology October 2017 28 Supplement 9:ix81-ix81 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|